WinSanTor
San Diego, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
SK
Stan KimExecutive
NC
Nigel CalcuttNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$782.9K disclosed across 1 round · 2017
▶$782.9KraisedNov 2017 · 16 investors · Pharmaceuticals
▶$782.9KraisedNov 2017 · 16 investors · Pharmaceuticals
Officers, directors & promoters on the filing
- Stan KimExecutive Officer, Director
- Nigel CalcuttDirector
- Offering amount
- $2M
- Amount sold
- $782.9K
- Minimum investment
- $20K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapUbie77 shared keywordsUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.
Doctronic50 shared keywordsDoctronic builds an AI system trained on peer-reviewed medical evidence to provide 24/7 medical triage and consultation, achieving 99.2% alignment with board-certified clinicians. The platform serves patients seeking instant healthcare guidance with no insurance requirement, anonymity, and HIPAA compliance.
Osmosis45 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Companies competing with WinSanTor for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who are WinSanTor's investors?
- WinSanTor's investors include Thynk Capital.
- How much funding has WinSanTor raised?
- WinSanTor has disclosed $782.9K raised across 1 round.
- Where is WinSanTor headquartered?
- WinSanTor is headquartered in San Diego, US.